TLDR:
- Women’s health startups saw gains in average deal sizes, percentage of healthcare venture capital funding, and attention in 2023.
- The average deal size for women’s health companies in 2023 reached a record high.
- These companies received an increasing percentage of venture capital raised by generalist healthcare companies.
- The federal government has shown increased involvement in women’s health, including the Initiative on Women’s Health Research and the Menopause Research and Equity Act.
- Women’s health unicorns have emerged, proving the value and potential of the industry.
- Female founders and CEOs in women’s health have increased their average deal sizes and set new fundraising records in 2023.
On November 13, 2023, the White House announced the first-ever Initiative on Women’s Health Research, aiming to fund women’s health, spur innovation, and improve many aspects of women’s health. Women’s health startups have seen gains in average deal size, percentage of healthcare venture capital funding, and attention, suggesting that 2024 may be a transformative year for the industry. Despite a challenging fundraising environment, women’s health companies managed to raise more capital per deal in 2023 than in previous years. They also received an increasing percentage of venture capital raised by generalist healthcare companies. Additionally, the federal government has shown increased involvement in women’s health, with the Initiative on Women’s Health Research and the Menopause Research and Equity Act. Women’s health unicorns have emerged, showing the industry’s value and potential. Female founders and CEOs in women’s health have raised larger average deals in 2023 compared to male founders and CEOs, setting new fundraising records. Overall, these trends indicate positive changes and potential growth for women’s health in 2024.
